How relevant and frequent is the presence of mild renal insufficiency in essential hypertension?

Journal of Clinical Hypertension

Volumn 4, Issue 5, 2002, Pages 332-336

  Segura, Julián ^a   Campo, Carlos ^a   Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; URINALYSIS;

EID: 0036751729     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2002.01003.x     Document Type: Article

References (23)

1. Woolfson RG, de Wardener HE. Primary renal abnormalities in hereditary hypertension. Kidney Int. 1996;50:717-731.
2. Locatelli F, Marcelli D, Cornelli M, et al. Proteinuria and blood pressure as casual components of progression to end-stage renal failure. Nephrol Dial Transplant. 1996;11:461-467.
3. Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol. 2001;12:218-225.
4. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366-372.
5. Mann JFE, Gerstein HC, Pogue J, et al. on behalf of the HOPE Investigators. Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: the HOPE randomization trial. Ann Intern Med. 2001;134(8):629-636.
6. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
7. Culleton BF, Larson MG, Wilson PWF, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56:2214-2219.
8. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
9. Segura J, Campo C, Fernández ML, et al. Control de la presión arterial: experiencia de una Unidad monográfica de Hipertensión arterial hospitalaria. Rev Clin Esp. 2001;201: 308-314.
10. National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System: Annual Data Report. Bethesda, MD: National Institutes of Health, 1989.
11. Ruilope LM, Alcazar JM, Rodicio JL. Renal consequences of arterial hypertension. J Hypertens. 1992;10(suppl 7):S85-S90.
12. Weisstuch JM, Dworkin LD. Does essential hypertension cause end-stage renal failure? Kidney Int. 1992;41 (suppl 36):S33-S37.
13. Mandhavan S, Stockwell D, Cohen H, et al. Renal function during antihypertensive treatment. Lancet. 1995;345:749-751.
14. Clase CM, Kiberd BA. Prevalence of renal insufficiency in non-diabetic adults: Third National Health and Nutrition Examination Survey (NHANES III)[abstract]. J Am Soc Nephrol. 2000;11:58A.
15. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2428.
16. Guidelines Subcommittee. World Health Organization, International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens. 1999;11:905-918.
17. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension. 1989;13(suppl I):180-193.
18. Ruilope LM, Campo C, Rodriguez-Artalejo F, et al. Blood pressure and renal function therapeutic implications. J Hypertens. 1996;14:1259-1263.
19. Kannel WB, Stampfer MJ, Castelli WP, et al. The prognostic significance of proteinuria. Am Heart J. 1984;108:1347-1352.
20. Samuelsson O. Hypertension in middle-aged man: management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand. 1985;702(suppl):1-79.
21. Tierney WM, Harris LE, Copley JB, et al. Effect of hypertension and type II diabetes on renal function in an urban population. Am J Hypertens. 1990;3:69-75.
22. Reaven GM, Lithell H, Landsberg L. Mechanisms of disease: hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
23. Lee J, Sparrow D, Vokonas PS, et al. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol. 1995;142:288-294.